Clinical Trial Begins for Vitamin Therapy Targeting Glaucoma Progression

Researchers at Karolinska Institutet are testing a vitamin-based metabolic therapy that showed promise in animal models by slowing or halting optic nerve damage without reducing intraocular pressure.